November 15, 2022, 16:41 GMT Five New Members Join the Board with Two New Leadership Positions Created Maureen McCall, Ph.D., CRF Scientific Advisory Board memberThe expanded Scientific Advisory
- Home
- |
- Author: Claire Wagner
Raising awareness for a rare degenerative retinal disease at the AAOPT Conference in San Diego, October 26-29, 2022
October 13, 2022, 00:14 GMT CRF celebrates 22 years of research progress and unwavering commitment to find a cure for a retinal disease that causes blindness “Vision care
Bhanu P. Telugu, PhD receives 3rd annual CRF Randy Wheelock Research Award
Bhanu P. Telugu, PhD, Randy Wheelock Award Winner September 13, 2022, 11:00 GMT Choroideremia Research Foundation supports development of first CHM porcine model to advance research for choroideremia,
CRF co-funds equipment to support research of CHM
Jasleen Jolly, DPhil MSc BSc (Hons) MCOptom August 18, 2022, 10:00 GMT MAIA Microperimeter System is a Vital Resource for Clinical Trial Measurement and Tracking of Chorideremia Eye
The CRF 2022 International Conference was a bright light on new research into CHM
August 14, 2022, 08:09 GMT 2022 CRF International Conference Top Researchers in the Field from Around the World Gather with Patients and Families We are thrilled with the
Choroideremia Research Foundation raise funds for disease
June 17, 2022, 06:12 AM EDT — FAIRPORT, N.Y. (WROC) — Officials with the Choroideremia Research Foundation announced their annual international conference at the Woodcliff Hotel & Spa
CRF award to Dr. Sena Gocuk to research female carriers of CHM
June 13, 2022, 11:00 GMT — Sena Gocuk, MSci, D-OPTOM, MPhil. studies the first longitudinal assessment of progression rates in phenotype categories. We are very excited to support
CRF announces research award to Dr. Vasiliki Kalatzis, researching critical CHM-related protein
June 06, 2022, 11:00 GMT — Dr. Vasiliki Kalatzis with Institute for Neurosciences in Montpellier, France. She focuses on the dysregulation of ion channels linked to RPE. Dr. Kalatzis’
CRF award supports new research for CHM applying antisense oligonucleotide (AON) therapy
May 23, 2022, 11:00 GMT – Ian MacDonald, MD, CM Dr. Ian MacDonald applies AON theory to stop aberrant splicing in CHM gene mutations. Dr. MacDonald’s research is
CHOROIDEREMIA RESEARCH FOUNDATION SUPPORTS NEW RESEARCH PATH
April 27, 2022, 10:00 GMT — Dr. Gamm’s proposal investigates other approaches for treating CHM, exploring new research paths that expand the scientific landscape. — Neal Bench, CRF